- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00113633
Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma
A Three-part Intervention to Improve Regular Care for Asthma After a Pediatric Emergency Department Visit: A Randomized Clinical Trial
Studieöversikt
Detaljerad beskrivning
Inner-city children are particularly at risk for poor asthma treatment outcomes and frequently obtain their asthma care in the ED. Prior studies have had limited success in improving primary care follow-up, quality of care, and long-term outcomes after a pediatric ED visit for asthma. Prior ED-based interventions have been designed to address barriers to follow-up with a primary care provider (PCP) such as an inability to obtain a follow-up appointment or lack of transportation. Focus groups and surveys of inner-city families have found that beliefs about the benefits of follow-up care and the role of preventive asthma medications have a strong impact on adherence to therapy.
This study will develop a brief educational video about the benefits of follow-up asthma care using a multi-disciplinary panel of experts at the Children's Hospital of Philadelphia and focus groups of parents of children with asthma. This educational video will then be combined into an intervention along with symptom screening and a reminder phone call that has been demonstrated to improve follow-up rates in a previous study. The combined intervention will be tested using a randomized trial design to determine its efficacy on healthcare utilization, asthma controller medication use, symptoms, and quality of life during the 6 months following an ED visit. The research is conducted as part of a research career development award.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Children's Hospital of Philadelphia
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age 1-18 years
- History of Asthma:
- At least 2 prior episodes of bronchodilator treatment
- No underlying cardiac disease
- No other chronic lung disease
- Residence within Philadelphia city limits
- Discharged from ED after treatment for asthma
Exclusion Criteria:
- Prior study enrollment
- Parent unable to speak English
- No telephone to be reachable for follow-up calls
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Control Subjects
These subjects will receive standard discharge instructions that recommend follow-up with a PCP within 3-5 days.
|
|
Experimentell: Intervention Subjects
As part of the intervention, the family will view a brief educational video about asthma control and therapy developed using provider and patient focus groups.
For children reporting persistent asthma symptoms, a letter will be given to the family to bring to their PCP stating that screening revealed symptoms that may require further treatment with controller medications.
A mailed reminder to schedule a follow-up appointment will be sent to the family.
|
The subject's family will view a brief educational video about asthma control and therapy developed using provider and patient focus groups; a mailed reminder will be sent to the family to schedule a follow-up appointment.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Follow-up with a Primary Care Physician (PCP)
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete the Parental Impressions of the Benefits (pros) and barriers (cons) of Follow-Up Care Scale (24-item instrument designed to measure perceived benefits and barriers to follow-up after an ED visit).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma-related follow-up visits which have been made to the Primary Care Physician.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Return to the Emergency Department for an asthma-related visit.
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit.
|
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma-related visits which have been made to the Emergency Department.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit.
|
Persistent asthma symptoms
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening instrument to assess the symptoms of persistent asthma (including cough, wheeze, shortness of breath).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about asthma symptoms and information will be compared to baseline.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Asthma Controller prescriptions by Primary Care Physician (PCP)
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history, site of primary care physician and current therapies.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of asthma controller medication prescriptions made by their Primary Care Physician.
Information provided by families will be verified by medical record review.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Asthma controller medication use
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history, site of primary care physician and current therapies.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about current asthma controller controller medication use.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Days of school/work missed
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects will complete a screening interview which will assess asthma history.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant after the initial Emergency Department visit.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the number of missed work/school days due to asthma-related reasons.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Peak expiratory flow
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, all subjects over the age of 6 will receive a peak expiratory flow meter and instruction as per standard care in the Emergency Department.
Follow-up telephone contact will be made by the Primary Investigator or a research assistant.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about peak expiratory flow meter testing since the initial Emergency Department visit.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Quality of life
Tidsram: 4 weeks, 3 months and 6 months after Emergency Department visit
|
At baseline, parents will be asked to complete the Integrated Therapeutics Group Child Asthma Short Form (8-item asthma-related quality of life questionnaire).
Follow-up telephone contact will be made by the Primary Investigator or a research assistant.
The person making the call will be unaware of the subjects group assignment (control or intervention).
Families will be asked about the asthma-related quality of life since the initial Emergency Department visit.
|
4 weeks, 3 months and 6 months after Emergency Department visit
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Joseph J. Zorc, Children's Hospital of Philadelphia
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2004-12-4130
- K23HL074250 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Intervention Subjects
-
BioMarin PharmaceuticalAvslutadFenylketonuriFörenta staterna
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Rekrytering
-
Biolux Research Holdings, Inc.AvslutadOrtodontisk tandrörelseKanada
-
University of FloridaAvslutadKänslighetFörenta staterna
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health...RekryteringHumant papillomvirusinfektionFörenta staterna
-
Roswell Park Cancer InstituteAvslutadFetma | Övervikt | Bröstcancer i anatomisk stadium I AJCC v8 | Bröstcancer i anatomiskt stadium IA AJCC v8 | Anatomiskt stadium IB Bröstcancer AJCC v8 | Anatomisk steg II bröstcancer AJCC v8 | Anatomiskt stadium IIA Bröstcancer AJCC v8 | Anatomiskt stadium IIB Bröstcancer AJCC v8 | Anatomisk steg III bröstcancer... och andra villkorFörenta staterna
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationAvslutad
-
M.D. Anderson Cancer CenterIndragenSteg IB3 Livmoderhalscancer FIGO 2018 | Steg II livmoderhalscancer FIGO 2018 | Steg IIA Livmoderhalscancer FIGO 2018 | Steg IIA1 Livmoderhalscancer FIGO 2018 | Steg IIA2 Livmoderhalscancer FIGO 2018 | Steg IIB Livmoderhalscancer FIGO 2018 | Steg III livmoderhalscancer FIGO 2018 | Steg IIIA Livmoderhalscancer... och andra villkor
-
Case Western Reserve UniversityAmerican University; Purdue UniversityRekrytering
-
Mayo ClinicAktiv, inte rekryterande